EISSN 2148-5607

TJG is categorized as Q3 in JIF. TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.6

Turkish Journal of Gastroenterology

36 433 2025

HIGHLY CITED ARTICLES

Correlation Between Kidney Function and Intestinal Biological Characteristics of Adenine and Folium SennaeInduced Diarrhea Model in Mice

Xiaoya Li, Jiayuan Zhu, Yi Wu, Zhoujin Tan

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Bernel et al.

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Kantarcıoğlu et al.

Epigenetics of Inflammatory Bowel Diseases

Törüner and Ünal

Vonoprazan on the Eradication of Helicobacter pylori Infection

Huang and Lin

Acute Pancreatitis Review

Huang and Badurdeen

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Original Article

Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer

Beste Melek ATASOY ¹ , Faysal DANE ² , Ayşegül ÜÇÜNCÜ KEFELİ ¹ , Hale ÇAĞLAR ¹ , Asım CİNGİ ³ , Nazım Serdar TURHAL ² , Ufuk ABACIOĞLU ¹ , Cumhur YEĞEN ³

Author Affiliation(s)

1.

Departments of Radiation Oncology

2.

Departments of Internal Medicine Division of Medical Oncology

3.

Departments of General Surgery, Marmara University School of Medicine, İstanbul

Turk J Gastroenterol 2011; 22: 60-64

DOI: 10.4318/tjg.2011.0158

Keywords : Chemoradiation, gemcitabine, low dose, pancreatic cancer, unresectable

Read: 2273 Downloads: 1829 Published: 25 July 2019

Volume 22, Issue 1, February 2011

Previous Article

Files